Skip to Content

Notice

Advisory Committees; Tentative Schedule of Meetings for 2004

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2004. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements IOM's recommendation.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register. FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on FDA's advisory committees' Internet site located at http://www.fda.gov/​oc/​advisory/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2004. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).

Committee NameDate(s) of MeetingsAdvisory Committee 10-Digit Information Line Code
OFFICE OF THE COMMISSIONER
Science Board to the Food and Drug AdministrationApril 22, November 43014512603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeApril 23014512388
Biological Response Modifiers Advisory CommitteeMarch 18-19, July 15-16, November 18-193014512389
Blood Products Advisory CommitteeMarch 18-19, July 12-13, October 21-223014519516
Transmissible Spongiform Encephalopathies Advisory CommitteeFebruary 12-13, June 29-30, October 14-153014512392
Start Printed Page 75575
Vaccines and Related Biological Products Advisory CommitteeFebruary 18-19, May 6-7, September 22-23, November 17-183014512391
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Life Support Drugs Advisory CommitteeMarch 24-25, June 9-10, August 10-11, November 17-183014512529
Anti-Infective Drugs Advisory CommitteeFebruary 2—Joint Meeting with Pediatric Subcommittee and Psychopharmacologic Drugs Advisory Committee, February 3-4—Pediatric Subcommittee3014512530
Antiviral Drugs Advisory CommitteeApril 27-28, October 27-283014512531
Arthritis Advisory CommitteeMay 12-13, July 14-15, October 21-223014512532
Cardiovascular and Drugs Health Advisory CommitteeMay 6-7, July 16, August 5-63014512533
Dermatologic and Ophthalmic Drugs Advisory CommitteeFebruary 26-27—Joint Meeting with Drug Safety and Risk Management Advisory Committee, April 1-2, May 6-7, June 24-25, August 26-27, September 9-103014512534
Drug Safety and Risk Management Advisory CommitteeFebruary 26-27—Joint Meeting with Dermatologic and Ophthalmic Drugs Advisory Committee, April 22-23, June 3-4, September 9-10, November 4-53014512535
Endocrinologic and Metabolic Drugs Advisory CommitteeFebruary 26-27, April 22-23, June 22-23, September 233014512536
Gastrointestinal Drugs Advisory CommitteeTo Be Announced3014512538
Nonprescription Drugs Advisory CommitteeMarch-Day To Be Announced June-Day To Be Announced December 16—Joint Meeting with Advisory Committee for Reproductive Health Drugs3014512541
Oncologic Drugs Advisory CommitteeMarch 16-17, June 15-163014512542
Peripheral and Central Nervous System DrugsTo Be Announced3014512543
Pharmaceutical Science, Advisory Committee forApril 13-143014512539
Psychopharmacologic Drugs Advisory CommitteeFebruary 2—Joint Meeting with Anti-Infective Drugs Advisory Committee and Pediatric Subcommittee3014512544
Pulmonary-Allergy Drugs Advisory CommitteeJune 29-30, November 4-53014512545
Reproductive Health Drugs, Advisory Committee forOctober—Day To Be Announced, December—Day To Be Announced3014512537
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory CommitteeSeptember 9-103014512398
Start Printed Page 75576
Medical Devices Advisory Committee (Comprised of 18 Panels)
Anesthesiology and Respiratory Therapy Devices PanelMarch 25-26, June 17-18, September 9-10, November 15-163014512624
Circulatory Systems PanelMarch 17-18, May 19-20, July 21-22, September 22-23, November 17-183014512625
Clinical Chemistry and Clinical Toxicology Devices PanelMarch 30-31, June 24-25, September 16-17, December 6-73014512514
Dental Products PanelApril 14-153014512518
Ear, Nose, and Throat Devices PanelApril 21-22, June 15-16, August 30-31, October 6-7, December 1-23014512522
Gastroenterology-Urology Devices PanelApril 30, July 16, October 223014512523
General and Plastic Surgery Devices PanelMarch 11-12, May 26-27, August 9-10, October 18-193014512519
General Hospital and Personal Use Devices PanelApril 6-7, July 12-13, October 18-193014512520
Hematology and Pathology Devices PanelApril 23, October 223014512515
Immunology Devices PanelFebruary 26, April 23, October 223014512516
Medical Devices Dispute Resolution PanelTo Be Announced as Needed3014510232
Microbiology Devices PanelApril 8-9, July 29-30, November 9-103014512517
Molecular and Clinical Genetics PanelApril 28-29, July 19-20, October 20-213014510231
Neurological Devices PanelFebruary 23, April 1-2, August 5-6, October 28-293014512513
Obstetrics and Gynecology Devices PanelApril 26-27, July 26-27, October 25-263014512524
Ophthalmic Devices PanelFebruary 5-6, March 4-5, May 13-14, July 8-9, September 22-23, November 4-53014512396
Orthopaedic and Rehabilitation Devices PanelMarch 22-23, June 3-4, August 12-13, December 2-33014512521
Radiological Devices PanelFebruary 3, May 18, August 10, November 163014512526
National Mammography Quality Assurance Advisory CommitteeApril 53014512397
Technical Electronic Product Radiation Safety Standards CommitteeNone3014512399
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory Committee—Full Committee and SubcommitteeAugust 16-173014510564
Additives and Ingredients SubcommitteeMay 26-273014510564
Biotechnology SubcommitteeJuly 21-223014510564
Contaminants and Natural Toxicants SubcommitteeNovember 16-173014510564
Start Printed Page 75577
Dietary Supplements SubcommitteeSeptember 14-153014510564
Infant FormulaJune 22-233014510564
Nutrition SubcommitteeMarch 30-313014510564
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeSeptember 23-243014512548
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
Science Advisory Board to National Center for Toxicological ResearchAugust 113014512559
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Herbicides and ContaminantsJanuary 21, April 12, August 3, October 263014512560
Start Signature

Dated: December 23, 2003.

Peter J. Pitts,

Associate Commissioner for External Relations.

End Signature End Supplemental Information

[FR Doc. 03-32103 Filed 12-30-03; 8:45 am]

BILLING CODE 4160-01-S